Simopoulos, A.P (2002). "The importance of the ratio of omega-6/omega-3 essential fatty acids". Biomedicine & Pharmacotherapy 56 (8): 365–79.
Age-Related Eye Disease Study 2 (AREDS2) research group. Lutein + zeaxanthin and omega-3 fatty acids for age-related macular degeneration. The Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial. JAMA. 2013;309(19):2005–2015.
Anandan C, Nurmatov U, Sheikh A. Omega 3 and 6 oils for primary prevention of allergic disease: systematic review and meta-analysis. Allergy. 2009;64(6):840–848.
Appleton KM, Rogers PJ, Ness AR. Updated systematic review and meta-analysis of the effects of n-3 long-chain polyunsaturated fatty acids on depressed mood. American Journal of Clinical Nutrition. 2010;91(3):757–770.
Bent S, Bertoglio K, Hendren RL. Omega-3 fatty acids for autistic spectrum disorder: a systematic review. Journal of Autism and Developmental Disorders. 2009;39(8):1145–1154.
Black LI, Clarke TC, Barnes PM, Stussman BJ, Nahin RL. Use of complementary health approaches among children aged 4‒17 years in the United States: National Health Interview Survey, 2007‒2012. [300K <a href=”#pdf”>PDF</a>] National health statistics reports; no 78. Hyattsville, MD: National Center for Health Statistics. 2015.
Brasky TM, Till C, White E, et al. Serum phospholipid fatty acids and prostate cancer risk: results from the prostate cancer prevention trial. American Journal of Epidemiology. 2011;173(12):1429–1439.
Buckley JD, Howe PR. Anti-obesity effects of long-chain omega-3 polyunsaturated fatty acids. Obesity Reviews. 2009;10(6):648–659.
Calder PC, Yaqoob P. Omega-3 polyunsaturated fatty acids and human health outcomes.Biofactors. 2009;35(3):266–272.
Chew EY, Clemons TE, Agrón E, et al. Effect of omega-3 fatty acids, lutein/zeaxanthin, or other nutrient supplementation on cognitive function. The AREDS2 randomized clinical trial. JAMA. 2015;314(8):791-801.
10.Chong EW-T, Kreis AJ, Wong TY, et al. Dietary omega-3 fatty acid and fish intake in the primary prevention of age-related macular degeneration. A systematic review and meta-analysis. Archives of Ophthalmology. 2008;126(6):826–833.
Clarke TC, Black LI, Stussman BJ, Barnes PM, Nahin RL. Trends in the use of complementary health approaches among adults: United States, 2002–2012 [240K <a href=”#pdf”>PDF</a>]. National health statistics reports; no 79. Hyattsville, MD: National Center for Health Statistics. 2015.
Covington MB. Omega-3 fatty acids. American Family Physician. 2004;70(1):133–140.
De Ley M, de Vos R, Hommes DW, et al. Fish oil for induction of remission in ulcerative colitis. Cochrane Database of Systematic Reviews. 2007;(4):CD005986 [edited 2008]. Accessed at www.thecochranelibrary.com(link is external) on November 2, 2012.
Farinotti M, Simi S, Di Pietrantonj C, et al. Dietary interventions for multiple sclerosis. Cochrane Database of Systematic Reviews. 2007;(1):CD004192 [edited 2009]. Accessed at www.thecochranelibrary.com(link is external) on November 2, 2012.
Fassett RG, Gobe GC, Peake JM, et al. Omega-3 polyunsaturated fatty acids in the treatment of kidney disease. American Journal of Kidney Diseases. 2010;56(4):728–742.
Filion KB, El Khoury F, Bielinski M, et al. Omega-3 fatty acids in high-risk cardiovascular patients: a meta-analysis of randomized controlled trials. BMC Cardiovascular Disorders. 2010;10:24.
Grey A, Bolland M. Clinical trial evidence and use of fish oil supplements. JAMA Internal Medicine. 2014;174(3):460-462.
Hooper L, Harrison RA, Summerbell CD, et al. Omega 3 fatty acids for prevention and treatment of cardiovascular disease. Cochrane Database of Systematic Reviews. 2004;(4):CD003177 [edited 2009]. Accessed at www.thecochranelibrary.com(link is external) on November 2, 2012.
Hu FB, Manson JE. Omega-3 fatty acids and secondary prevention of cardiovascular disease—is it just a fish tale? Archives of Internal Medicine. 2012;172(9):694–696.
Huang TL. Omega-3 fatty acids, cognitive decline, and Alzheimer’s disease: a critical review and evaluation of the literature. Journal of Alzheimer’s Disease. 2010;21(3):673–690.
Irving CB, Mumby-Croft R, Joy LA. Polyunsaturated fatty acid supplementation for schizophrenia. Cochrane Database of Systematic Reviews. 2006;(3):CD001257 [edited 2010]. Accessed at www.thecochranelibrary.com(link is external) on November 2, 2012.
Kris-Etherton PM, Harris WS, Appel LJ, et al. Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Circulation. 2002;106(21):2747–2757.
Kwak SM, Myung S-K, Lee YJ, et al. Efficacy of omega-3 fatty acid supplements (eicosapentaenoic acid and docosahexaenoic acid) in the secondary prevention of cardiovascular disease. A meta-analysis of randomized, double-blind, placebo-controlled trials. Archives of Internal Medicine. 2012;172(9):686–694.
Lee JH, O’Keefe JH, Lavie CJ, et al. Omega-3 fatty acids: cardiovascular benefits, sources and sustainability. Nature Reviews. Cardiology. 2009;6(12):753–758.
Miles EA, Calder PC. Influence of marine n-3 polyunsaturated fatty acids on immune function and a systematic review of their effects on clinical outcomes in rheumatoid arthritis. British Journal of Nutrition. 2012;107(Suppl 2):S171–S184.
Oh R. Practical applications of fish oil (omega-3 fatty acids) in primary care. Journal of the American Board of Family Practice. 2005;18(1):28–36.
Oliver C, Everard M, N’Diaye T. Omega-3 fatty acids (from fish oils) for cystic fibrosis. Cochrane Database of Systematic Reviews. 2007;(4):CD002201 [edited 2010]. Accessed at www.thecochranelibrary.com(link is external) on November 2, 2012.
Raz R, Gabis L. Essential fatty acids and attention-deficit-hyperactivity disorder: a systematic review. Developmental Medicine and Child Neurology. 2009;51(8):580–592.
Riediger ND, Othman RA, Suh M, et al. A systemic review of the roles of n-3 fatty acids in health and disease. Journal of the American Dietetic Association. 2009;109(4):668–679.
Rizos EC, Ntzani EE, Bika E, et al. Association between omega-3 fatty acid supplementation and risk of major cardiovascular disease events. A systematic review and meta-analysis.JAMA. 2012;308(10):1024–1033.
Salari P, Rezaie A, Larijani B, et al. A systematic review of the impact of n-3 fatty acids in bone health and osteoporosis. Medical Science Monitor. 2008;14(3):RA37–44.
Saravanan P, Davidson NC, Schmidt EB, et al. Cardiovascular effects of marine omega-3 fatty acids. Lancet. 2010;376 (9740):540–550.
Szymanski KM, Wheeler DC, Mucci LA. Fish consumption and prostate cancer risk: a review and meta-analysis. American Journal of Clinical Nutrition. 2010;92(5):1223–1233.
Turner D, Zlotkin SH, Shah PS, et al. Omega 3 fatty acids (fish oil) for maintenance of remission in Crohn’s disease. Cochrane Database of Systematic Reviews. 2009;(1):CD006320. Accessed at www.thecochranelibrary.com(link is external) on November 2, 2012.
Weitz D, Weintraub H, Fisher E, et al. Fish oil for the treatment of cardiovascular disease.Cardiology in Review. 2010;18(5):258–263.